Adherence with statin therapy in elderly patients with and without acute coronary syndromes
- PMID: 12132976
- DOI: 10.1001/jama.288.4.462
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
Abstract
Context: Landmark clinical trials have demonstrated the survival benefits of statins, with benefits usually starting after 1 to 2 years of treatment. Research prior to these trials of older lipid-lowering agents demonstrated low levels of 1-year adherence.
Objective: To compare 2-year adherence following statin initiation in 3 cohorts of patients: those with recent acute coronary syndrome (ACS), those with chronic coronary artery disease (CAD), and those without coronary disease (primary prevention).
Design and setting: Cohort study using linked population-based administrative data from Ontario.
Patients: All patients aged 66 years or older who received at least 1 statin prescription between January 1994 and December 1998 and who did not have a statin prescription in the prior year were followed up for 2 years from their first statin prescription. There were 22,379 patients in the ACS, 36,106 in the chronic CAD, and 85,020 in the primary prevention cohorts.
Main outcome measures: Adherence to statins, defined as a statin being dispensed at least every 120 days after the index prescription for 2 years.
Results: Two-year adherence rates in the cohorts were only 40.1% for ACS, 36.1% for chronic CAD, and 25.4% for primary prevention. Relative to the ACS cohort, nonadherence was more likely among patients receiving statins in the chronic CAD (relative risk [RR], 1.14; 95% CI, 1.11-1.16) and primary prevention cohorts (RR, 1.92; 95% CI, 1.87-1.96).
Conclusions: Elderly patients with and without recent ACS have low rates of adherence to statins. This suggests that many patients initiating statin therapy may receive no or limited benefit from statins because of premature discontinuation.
Comment in
-
Elderly patients' adherence to statin therapy.JAMA. 2002 Jul 24-31;288(4):495-7. doi: 10.1001/jama.288.4.495. JAMA. 2002. PMID: 12132982 No abstract available.
Similar articles
-
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.Heart. 2007 Aug;93(8):945-51. doi: 10.1136/hrt.2006.110197. Epub 2007 Mar 7. Heart. 2007. PMID: 17344334 Free PMC article.
-
Intensive statin therapy for treating acute coronary syndromes.Expert Opin Investig Drugs. 2006 Oct;15(10):1151-9. doi: 10.1517/13543784.15.10.1151. Expert Opin Investig Drugs. 2006. PMID: 16989592 Review.
-
Long-term persistence in use of statin therapy in elderly patients.JAMA. 2002 Jul 24-31;288(4):455-61. doi: 10.1001/jama.288.4.455. JAMA. 2002. PMID: 12132975
-
Early statin initiation and outcomes in patients with acute coronary syndromes.JAMA. 2002 Jun 19;287(23):3087-95. doi: 10.1001/jama.287.23.3087. JAMA. 2002. PMID: 12069671
-
Early use of statins in acute coronary syndromes.Curr Cardiol Rep. 2002 Jul;4(4):289-97. doi: 10.1007/s11886-002-0064-y. Curr Cardiol Rep. 2002. PMID: 12052268 Review.
Cited by
-
Co-Design, Development, and Evaluation of a Mobile Solution to Improve Medication Adherence in Cancer: Design Science Research Approach.JMIR Cancer. 2024 Apr 3;10:e46979. doi: 10.2196/46979. JMIR Cancer. 2024. PMID: 38569178 Free PMC article.
-
Adherence to Medications in Patients with Ischaemic Heart Disease in Oman.Sultan Qaboos Univ Med J. 2024 Feb;24(1):109-114. doi: 10.18295/squmj.7.2023.045. Epub 2024 Feb 28. Sultan Qaboos Univ Med J. 2024. PMID: 38434452 Free PMC article.
-
Healthy lifestyle, statin, and mortality in people with high CVD risk: A nationwide population-based cohort study.Am J Prev Cardiol. 2024 Jan 24;17:100635. doi: 10.1016/j.ajpc.2024.100635. eCollection 2024 Mar. Am J Prev Cardiol. 2024. PMID: 38327628 Free PMC article.
-
Improving medication adherence in cardiovascular disease.Nat Rev Cardiol. 2024 Jun;21(6):417-429. doi: 10.1038/s41569-023-00972-1. Epub 2024 Jan 3. Nat Rev Cardiol. 2024. PMID: 38172243 Review.
-
Effect of statin treatment on metabolites, lipids and prostanoids in patients with Statin Associated Muscle Symptoms (SAMS).PLoS One. 2023 Dec 15;18(12):e0294498. doi: 10.1371/journal.pone.0294498. eCollection 2023. PLoS One. 2023. PMID: 38100464 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous